POOR LONG-TERM OUTCOME OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN NONPROLIFERATIVE MACULAR TELANGIECTASIA TYPE 2
2019 ◽
Vol 206
◽
pp. 176-183
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 524-524
◽
2016 ◽
Vol 32
(4)
◽
pp. 219-224
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 524-524
◽
2016 ◽
Vol 172
◽
pp. 72-79
◽